# The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

> **NCT06084585** · NA · UNKNOWN · sponsor: **Amway (China) R&D Center** · enrollment: 180 (estimated)

## Conditions studied

- Hyperuricemia

## Interventions

- **DIETARY_SUPPLEMENT:** Study Product A (High-dose 2X)
- **DIETARY_SUPPLEMENT:** Study Product B (Low-dose X)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06084585
- **Lead sponsor:** Amway (China) R&D Center
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-23
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-03-15
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084585, "The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06084585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*